More Impedimed Limited news
Impedimed LimitedASX: IPD

Appendix 4C - Quarter Ended 30 September 2016

Oct 25, 2016 at 9:57 PM EDT · Issued by Impedimed Limited

Filed with ASX · Oct 25, 2016 at 9:57 PM EDT

On 6ix: 6ix.com/news/appendix-4c-quarter-ended-30-september-2016

Watch Impedimed's latest call↗Impedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings Call↗

Impedimed Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Impedimed Limited on 6ix

Earlier from Impedimed

  • Study on Efficacy of L-Dex in Routine Clinical PracticeSep 13, 2016
  • Appendix 4E and Press ReleaseAug 23, 2016
  • SOZO Launched - First Product for Health and Wellness MarketAug 11, 2016
  • Scripps to use SOZO in Heart Failure StudyAug 9, 2016
  • Appendix 4C - Quarter Ended 30 June 2016Jul 28, 2016

Later from Impedimed

  • Appendix 4C - Quarter Ended 31 December 2016Jan 30, 2017
  • Appendix 4D and Financial Report 31 December 2016Feb 23, 2017
  • Placement of First SOZO Unit at Scripps HealthMar 6, 2017
  • SOZO Shipped to Vanderbilt to Commence At-Home StudyApr 23, 2017
  • March 2017 Quarter Results & Investor Conference CallApr 25, 2017
All Impedimed news releases↗

Follow Impedimed into a list and get an email when it puts out news.

Follow Impedimed
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer